Peer Review History

Original SubmissionNovember 21, 2021
Decision Letter - Chih-Horng Kuo, Editor

PONE-D-21-36966An entomopathogenic strain of Serratia ureilytica is associated with mortalities in a captive colony of the critically endangered phasmid Dryococelus australisPLOS ONE

Dear Dr. Allen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chih-Horng Kuo, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. 

  

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Additional Editor Comments:

Please check the PLOS ONE Criteria for Publication (https://journals.plos.org/plosone/s/criteria-for-publication) when planning the revision.

Specifically, the experiments need to be described in sufficient details and the conclusions (including the title) must be supported by the data presented.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: My only suggested edit is to define MLST on line 72. Otherwise, the manuscript is excellent, the English level is fluent, and I have no further edits to recommend.

Reviewer #2: The title of the study is “ An entomopathogenic strain of Serratia ureilytica is associated with mortalities in a captive colony of the critically endangered phasmid Dryococelus australis”. However, it did not reflect the genetic characterization of the Serratia strains isolated from Dryococelus australis and its phylogenetic relationship with Serratia genus. I suggest that the title be changed to a title that shows all the work done in the present work..

The objectives of this research were: genome sequencing of two representative strains and they were compared with genomes of Serratia spp. Publicly available, including entomopathogenic strains. The virulence of a selected isolate was evaluated in experimentally infected honey bees (Apis mellifera).

Hemolymph samples were collected from necropsies of D. australis within the Melbourne Zoo colony that died or were found moribund and euthanized. Serratia, Pseudomonas or Aeromonas and Proteus were isolated from the samples. In addition, environmental samples [nest boxes, floors, drinking water and frass (insect excrement)] were collected.

Molecular typing was performed for Serratia strains based on PFGE and Fingerprinting rep-PCR. For Illumina sequencing, it was performed from two representative strains:: S. ureilytica AM923 and S. marcescens AM1004. The nucleotide sequencing of each strain was analyzed and prophages, genomic islands, antimicrobial resistance genes, and virulence were identified. On the other hand, a phylogenetic and pangenomic analysis was carried out against representative genomes of the genus Serratia downloaded from databases.

The virulence assay was carried out on bees; and finally, the nuclease (nucA) and urease beta subunit (ureB) genes were amplified.

I don't understand why the sequence of strain AM923 was chosen as the main reference genome and an in-depth analysis was performed, while strain AM1004 was used for comparative purposes. In this case, although the genotype of the strain AM923 was the predominant one in relation to AM1004, both genotypes were found in the samples. I think that both strains should be studied with the same interest, for example, both are reported in other Zoo. This means that both genotypes are circulating in the region and it is not known whether they can infect other types of hosts that are equally susceptible to infection by both types of strains.

It would also be desirable to perform virulence tests for strain AM1004.

Regarding the sequence of the urease operon that could be used for the detection of entomopathogenic strains of Serratia, a statistical analysis is recommended to validate this statement.

The presence of one or two pulsotypes of Serratia strains associated with the infection or death of Dryococelus australis, suggests an epidemic outbreak in the D. australis colony at Melbourne Zoo by one or two strains. It would be important to have the exact date on which the infection occurred in the insects and to relate them to the genetic characteristics of the strains. In addition, to determine the source of infection, it would be good to point out the origin of the environmental samples [nests, floor surfaces, drinking water and frass (insect excrement)] that were contaminated with Serratia, and sequence it, to compare the genome of the Serratia strain isolated from the environmental sample with the genome of the Serratia strain isolated from samples of insect hemolymph.

In general, the work is good, however I feel that the main objective is missing, which is the characterization of Serratia spp. strains associated with infection and death of the D. australis colony at Melbourne Zoo.

The authors focused on determining the phylogeny and taxonomy of Serratia genus.

In conclusion, I recommend that the authors rethink the title of the article and the objectives.

Reviewer #3: Paper outlines the isolation of insect pathogens and follows the route of species identification using in silico approaches.

To provide context it would be of value to expand on the insect raring conditions, the food source etc and how this in turn may relate to their natural habitat. From here can then associate with Serratia species

Though I see the rational for the use of Bees as a proxy for stick insects, which in turn may explain the use of 37 Celsius microbial growth parameters. Assessing an insect from the same family might be more preferable, more so as many insect pathogens are host specific

In relation to the disease are there any photos of the diseased insect. I note histology mentioned L103, some images would be of value - where is this data .

Table S4 lists observed plaques wherein some photos would help or for that matter more detailed bioassay data, host range and dose response data would be of value

In general greater detail could be provided in Figure legends

I feel that as written the manuscript is too focused on use of in silico approaches to define species and needs to be bolstered in mode of action and bioassay data more so to provide relevance to the study and for that matter the phasmid. In silico analysis can then assess for presence of insect active enzymes/toxins etc . In addition to this more information on how this study could help with raring phasmids in the discussion would be of value

Virulence assay

I am left unsure on the definition of carriage or a timeframe (line 465 denotes 6 days), I am left asking several questions :-

were they surface sterilised prior to isolation

was a dilution series undertaken prior platting

what is the dominance of the isolated bacteria relative to the other isolated bacteria -if any. In this context Table 1 lists some numbers. In this respect n=127 does this mean colonies total from an insect ? or something else - please clarify and provide a quantifiable measure , a foot note on definition of pure and mixed would be useful

L211 I am unsure of this assay it read as a direct immersion of a bee in a solution of bacteria based on the provide information it is hard to know how the bacteria gets ingested via this technique , perhaps using a sucrose bacteria solution applied to a dental wick might be more apt

Kochs postulates i.e. would be nice to see i.e. re feed the suspected bacteria back to the insect species it was isolated from to see affect again . I appreciate a rare insect so perhaps a closely related species might act as a more suitable proxy than the honey bee

In addition it appears the bacteria were reisolated and validated through PCR were the insects surface sterilised prior to this step?? I am mainly concerned with PCR sensitivity and its ability to differentiate live verse dead (DNA) cells . In this context platting out is a likely more applicable method more so if we assume that a pathogen might multiply and dominate the microbial population. It would be good to have a quantifiable measure eg from each cadaver ## bacteria were isolated

Phylogenies are not my expertise , this study are restricted based on species where sequenced genomes are available, this is okay but I think a MLST /16S encompassing all Serratia species (Type strains – of which data is available ) would help complement the extensive genome based phylogenies and help the reader better understand where the Serratia strain fits and of course interpretation of the data.

The authors also allude to the role of chitinases etc L559 in other systems but I am unsure if they assessed this in the genomes sequenced in this study. L553-560 are pertinent points and leaves the reader wondering what accessory virulence determinants are in the assessed Serratia genome - in this context a preliminary genome assessment of Haemolysin chitinase etc would be of value . This is possibly more relevant than Urease

Fig S2 is nice given a finite set of Serratia species (due to genome access limitations), please reference genome accession numbers. This is also applicable for other figures and Tables (I might have missed this information)

Of interest in the discussion the authors acknowledge and discuss many of the issues I have raised such as use of bee model etc

Minor comments are as per below

L37 Based on in silico analysis ? a urease operon …..

L52 could list food source

L57 is bacilli the correct term please check is this relating to Serratia? might be rods? I am unsure

L61 -62 why have we singled out these the Serratia specie?

L102 rational for using SBA and MAC? latter L118 LB then L130 TSB then used? I note MAC is used to selectively isolate Gram-negative and enteric bacteria

L103 is there a rational for 37C just curious might be of interest to understand the ambient temperature the phasmids insects are in

L118 perhaps mention cycloheximide is an anti fungal

L120 could get the 16s of the bacteria sequenced - in addition is there a predominant isolate

Figure 6 Time? I assume days post challenge please provide value, I am unsure what number at risk relates to.

L212 full genus for E coli

L213 has PBS been written in full and components provided?

Table S7 I am unsure of the relevance of this Table

L223 what is a cup cage perhaps dimensions could be provided?

L319 could list the program used prior to … Using #### the chromosome was predicted

L489 what is defined as a harsh environment

Fig S1 mention why a subset of isolates are red hashed boxed. i.e. red hashed boxed denotes Lord H..

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Matan Shelomi

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We would like to thank the reviewers for their helpful comments and questions. Our detailed responses to the reviewers' remarks and questions are covered in the document 'Response to reviewers'.

Attachments
Attachment
Submitted filename: PlosONE Sureilytica response to reviewers (1).docx
Decision Letter - Chih-Horng Kuo, Editor

PONE-D-21-36966R1Genomic characterisation of an entomopathogenic strain of Serratia ureilytica in the critically endangered phasmid Dryococelus australisPLOS ONE

Dear Dr. Allen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Chih-Horng Kuo, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments:

Reviewer #3 provided additional comments to be addressed. I agree with the concern that the Discussion section is difficult to read, perhaps dividing into sub-sections with clear headings would help.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #3: The paper is much improved, specifically the introduction and the results, however the discussion lacks a clear focus and highlighting the outcomes of the study --and could be reworked . The responces in places are good but I might suggest that they accordingly update the manuscript with the information in the response provided

A photo of a diseased insect referenced in Bayley however I am left unsure if isolates from the Bayley paper were included in this study? if so please highlight this, if not this would further warrant the inclusion of a photo/histology from where it could be compared to that of Bayley et al

L120 I am still left unsure of what insects are feeding on - what is the plant material is it fresh a live plant etc??

L125 right LB in full first time mentioned

L280 perhaps put a descriptor on what the other groups are

L343 344 list % ANI value after each species name in brackets

L464 for future reference you could incorporate through primer synthesis in generic primer base at points of difference e.g. a N or a Y etc

L497 what is the extreme variable salinity , temp or other?? please update as per responce

Discussion -reads as disjointed and seems to focus on negatives detracting from the reading. I believe a discussion should be written in a positive context and highlighting key results

L503 do we mean isolated as a pure culture ? ….L504-505 could be deleted as detracts from the prior sentence

L505-506 are there pictures of the histology and I would possibly shift sentence to latter on after you have discussed the bacteria

L514 paragraph. I still think we need to be quantitative did Pseud and Prot dominate the % microbes isolated from these insects

L532 clarify who submitted the sequences to NCBI , if they -are from this study the sentence can be removed and leave it to NCBI to reassign the species , please clarify

L533-L539 may irk some readers could reduce text here and often good to cross reference/compare to a type strains, we can assume there is a lot of rubbish in the NCBI database,

L534 what do we mean by reinterpreted I might have suggested that these strains be included further strengthening the article

L541 this paragraph seems to have no value , what is its context and how does it relate to the results in this study

L606 what are these genomic targets

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Rosario Morales-Espinosa

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Thank you for providing us with the opportunity to submit a revised version of our manuscript.

Our response to Reviewer #3's comments are addressed in the attached Response to Reviewers document.

Attachments
Attachment
Submitted filename: Response to reviewers submission 2.docx
Decision Letter - Chih-Horng Kuo, Editor

Genomic characterisation of an entomopathogenic strain of Serratia ureilytica in the critically endangered phasmid Dryococelus australis

PONE-D-21-36966R2

Dear Dr. Allen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chih-Horng Kuo, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Chih-Horng Kuo, Editor

PONE-D-21-36966R2

Genomic characterisation of an entomopathogenic strain of Serratia ureilytica in the critically endangered phasmid Dryococelus australis

Dear Dr. Allen:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chih-Horng Kuo

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .